Chinmaya Rath
Corporate Officer/Principal en GLYCOMIMETICS, INC. .
Fortuna: 275 614 $ al 30/04/2024
Perfil
Chinmaya Rath is the founder of Cellurx.
He is currently the Director at Catena Biosciences, Inc., the Chief Business Officer & Senior Vice President at GlycoMimetics, Inc., and a Venture Partner at Social Impact Capital, Inc. He holds an MBA from Warwick Business School and an undergraduate degree from Ravenshaw University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GLYCOMIMETICS, INC.
0.25% | 12/01/2024 | 161 178 ( 0.25% ) | 275 614 $ | 30/04/2024 |
Cargos activos de Chinmaya Rath
| Empresas | Cargo | Inicio |
|---|---|---|
| GLYCOMIMETICS, INC. | Corporate Officer/Principal | - |
Catena Biosciences, Inc.
 Catena Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Catena Biosciences, Inc. is an American biotech company that was founded in May 2021. The company is based in El Cerrito, CA. The company is based on technology developed in the Doudna and Francis labs at the University of California, Berkeley. Catena Biosciences' patented technology, called the Catenase platform, allows the construction of biomolecules that are currently unobtainable using modern manufacturing techniques. The platform has applications across multiple therapeutic areas, with an initial focus in oncology. The company is the recipient of an NIH SBIR grant and the American Cancer Society's BrightEdge Golden Ticket at UC's Bakar Labs. The company was founded in 2020 by Marco Lobba, Gregorio Guillen, Matthew B. Francis. Marco Lobba has been the CEO since 2020. | Director/Miembro de la Junta | - |
| Cellurx | Director Ejecutivo | - |
Social Impact Capital, Inc.
 Social Impact Capital, Inc. Investment ManagersFinance Social Impact Capital LLC (Social Impact) is a Venture Capital firm founded in 2015 by Sarah Cone. The firm is headquartered in New York. | Inversor de Capital Privado | 01/11/2022 |
Formación de Chinmaya Rath.
| Warwick Business School | Masters Business Admin |
| Ravenshaw University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| GLYCOMIMETICS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Social Impact Capital, Inc.
Social Impact Capital, Inc. Investment ManagersFinance Social Impact Capital LLC (Social Impact) is a Venture Capital firm founded in 2015 by Sarah Cone. The firm is headquartered in New York. | Finance |
Catena Biosciences, Inc.
Catena Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Catena Biosciences, Inc. is an American biotech company that was founded in May 2021. The company is based in El Cerrito, CA. The company is based on technology developed in the Doudna and Francis labs at the University of California, Berkeley. Catena Biosciences' patented technology, called the Catenase platform, allows the construction of biomolecules that are currently unobtainable using modern manufacturing techniques. The platform has applications across multiple therapeutic areas, with an initial focus in oncology. The company is the recipient of an NIH SBIR grant and the American Cancer Society's BrightEdge Golden Ticket at UC's Bakar Labs. The company was founded in 2020 by Marco Lobba, Gregorio Guillen, Matthew B. Francis. Marco Lobba has been the CEO since 2020. | Commercial Services |
| Cellurx |
- Bolsa de valores
- Insiders
- Chinmaya Rath
